The Technical Analyst
Medpace Holdings Inc [MEDP]
Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research
Medpace Holdings Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
-0.62% $372.00
America/New_York / 19 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 11 442 mill |
| EPS: | 8.87 |
| P/E: | 41.94 |
| Earnings Date: | Apr 22, 2024 |
| SharesOutstanding: | 30.76 mill |
| Avg Daily Volume: | 0.254 mill |
| RATING 2024-04-19 |
|---|
| S |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Strong Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 41.94 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 2.24x |
| Company: PE 41.94 | industry: PE 18.71 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$374.74 (0.74%) $2.74 |
| Date: 2024-04-20 |
| Expected Trading Range (DAY) |
|---|
|
$ 362.08 - 381.92 ( +/- 2.67%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-31 | Kraft Robert O. | Buy | 72 | Common Stock |
| 2024-03-31 | Kraft Robert O. | Sell | 72 | Restricted Stock Unit |
| 2024-03-31 | Mccarthy Cornelius P. Iii | Buy | 63 | Common Stock |
| 2024-03-31 | Mccarthy Cornelius P. Iii | Sell | 63 | Restricted Stock Unit |
| 2024-03-31 | Carley Brian T | Buy | 79 | Common Stock |
| INSIDER POWER |
|---|
| -94.48 |
| Last 100 transactions |
| Buy: 69 002 | Sell: 2 472 032 |
Forecast:
16:00 - $371.59
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $371.59
Forecast 2: 16:00 - $371.59
Forecast 3: 16:00 - $371.59
SCORE
-10.00
Sell
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $372.00 (-0.62% ) |
| Volume | 0.222 mill |
| Avg. Vol. | 0.254 mill |
| % of Avg. Vol | 87.27 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MEDP
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | buy | $318.05 | N/A | Active |
|---|
MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Last 10 Buy Signals
Latest Press Releases
2024-03-28 16:05:00 - Press Release
Medpace Holdings, Inc. To Report First Quarter 2024 Financial Results On April 22, 2024
Cincinnati--(business wire)--medpace holdings, inc. (nasdaq: medp) (“medpace”) today announced that it will report its first quarter 2024 financial results after the market close on monday, april 22, 2024. the company will host a conference call the following morning, tuesday, april 23, 2024, at 9:00 a.m. et to discuss these results. to participate in the conference call, interested parties must register in advance by clicking on this link. while it is not required, it is recommended you join 1.
2024-02-12 16:15:00 - Press Release
Medpace Holdings, Inc. Reports Fourth Quarter And Full Year 2023 Results
Cincinnati--(business wire)--medpace holdings, inc. (nasdaq: medp) (“medpace”) today announced financial results for the fourth quarter and full year ended december 31, 2023. fourth quarter 2023 financial results revenue for the three months ended december 31, 2023 increased 26.5% to $498.4 million, compared to $394.1 million for the comparable prior-year period. on a constant currency basis, revenue for the fourth quarter of 2023 increased 26.0% compared to the fourth quarter of 2022. backlog.
2024-01-03 16:05:00 - Press Release
Medpace Holdings, Inc. To Report Fourth Quarter And Fiscal Year 2023 Financial Results On February 12, 2024
Cincinnati--(business wire)--medpace holdings, inc. (nasdaq: medp) (“medpace”) today announced that it will report its fourth quarter and fiscal year 2023 financial results after the market close on monday, february 12, 2024. the company will host a conference call the following morning, tuesday, february 13, 2024, at 9:00 a.m. et to discuss these results. to participate in the conference call, interested parties must register in advance by clicking on this link. while it is not required, it is.
2023-10-23 16:15:00 - Press Release
Medpace Holdings, Inc. Reports Third Quarter 2023 Results
Cincinnati--(business wire)--medpace holdings, inc. (nasdaq: medp) (“medpace”) today announced financial results for the third quarter ended september 30, 2023. third quarter 2023 financial results revenue for the three months ended september 30, 2023 increased 28.3% to $492.5 million, compared to $383.7 million for the comparable prior-year period. on a constant currency basis, revenue for the third quarter of 2023 increased 27.6% compared to the third quarter of 2022. backlog as of september.
2023-09-26 16:05:00 - Press Release
Medpace Holdings, Inc. To Report Third Quarter 2023 Financial Results On October 23, 2023
Cincinnati--(business wire)--medpace holdings, inc. (nasdaq: medp) (“medpace”) today announced that it will report its third quarter 2023 financial results after the market close on monday, october 23, 2023. the company will host a conference call the following morning, tuesday, october 24, 2023, at 9:00 a.m. et to discuss these results. to participate in the conference call, interested parties must register in advance by clicking on this link. while it is not required, it is recommended you jo.
Latest News
2024-04-15 11:05:48 - Zacks Investment Research
Medpace (MEDP) Earnings Expected to Grow: Should You Buy?
Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2024-04-05 13:16:12 - Zacks Investment Research
Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report?
Medpace (MEDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
2024-03-30 09:16:19 - Investors Business Daily
Uber Leads Five Stocks Near Buy Points
Uber, Axon and one more stock with the highest-possible rating from IBD lead this weekend's watch list.
2024-03-28 09:51:08 - Zacks Investment Research
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
2024-03-05 07:11:05 - Zacks Investment Research
4 Best Profitable Stocks to Invest in Using Net Income Ratio
Trip.com Group Limited (TCOM), Medpace (MEDP), Centrus Energy (LEU) and NVIDIA (NVDA) have been selected as the top picks with a high net income ratio.
2024-03-04 13:46:06 - Zacks Investment Research
Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why
Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.
2024-03-04 13:01:11 - Zacks Investment Research
Medpace (MEDP) Is Up 0.64% in One Week: What You Should Know
Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.
2024-02-28 18:26:08 - Zacks Investment Research
These 3 Buy-Rated Stocks Have Been Red-Hot
While February is generally known to be a bit cold, these three stocks have been red-hot, rewarding investors considerably following strong quarterly results.
2024-02-22 08:11:09 - Zacks Investment Research
5 Best Profitable Stocks to Buy Using Net Income Ratio
Trip.com Group Limited (TCOM), Medpace (MEDP), Centrus Energy (LEU), Suzano (SUZ) and NVIDIA (NVDA) have been selected as the top picks with a high net income ratio.
2024-02-15 13:45:31 - Zacks Investment Research
3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)
Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.